PCE

In this podcast, Brett M. Elicker, MD, and David E. Griffith, MD, ATSF, FACCP, FRSM, discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE, including: The vicious vortex of NCFBE (ie, airway dysfunction, inflammation, infection) Cough as the most significant symptom and burden Imaging bronchiectasis with classic and inflammatory findings Differentiating the causes of NCFBE to inform patient care Presenters Brett M. Elicker, MD Professor of Clinical Radiology Chief, Cardiothoracic Imaging Division Department of Radiology & Biomedical Imaging University of California, San Francisco San Francisco, California David E. Griffith, MD, ATSF, FACCP, FRSM Professor of Medicine Division of Mycobacterial and Respiratory Diseases Department of Medicine National Jewish Health Denver, Colorado Program page:  https://bit.ly/4mZbYsm

Respiratory Syncytial Virus (RSV) significantly impacts adults, especially those over age 60 and those with chronic conditions. In this podcast, nurse practitioners Drs. Carrico and Stevenson discuss the underestimated burden of RSV. The podcast also explores practical strategies for increasing vaccine uptake that you can apply to your practice starting today so that you can protect your patients against RSV. Listen as they discuss: The Burden of Adult RSV RSV Vaccines for Adults: Data and Recommendations RSV Vaccine Uptake Practical Strategies to Increase RSV Vaccine Uptake Faculty: Dr. Ruth Carrico is a family nurse practitioner and senior consultant with Carrico & Ramirez, PLLC focused on infectious diseases, infection prevention and control, and vaccinology.  She is based in Louisville, Kentucky and is a Professor, adjunct faculty, with the University of Louisville School Medicine, Division of Infectious Diseases. Dr. Carrico has received training specific for healthcare epidemiology at the Centers for Disease Control and Prevention (CDC) in conjunction with the Rollins School of Public Health at Emory University in Atlanta and the Society for Healthcare Epidemiology of America (SHEA).  Dr. Carrico has worked in the field of infectious diseases and infection control for more than thirty years.  Dr. Carrico also maintains a clinical practice focused on vaccines, vaccination, and immunization processes. Dr. Audrey M. Stevenson is a family nurse practitioner with over 40 years of clinical, public health, and leadership experience.  Dr. Stevenson, who holds a master of public health and master of nursing degrees, received her doctorate in public health from the University of Utah. She formerly worked in public health for over 34 years and was the former Division Director of Family Health and Clinical Services of the Salt Lake County Health Department in Salt Lake City, Utah. She currently works as a consultant and teaches graduate FNP and MPH students at two universities.  Dr. Stevenson is also a member of the statewide vaccine advisory board, where she collaborates on vaccine policies and recommendations for the state. Previously, Dr. Stevenson served as Vaccination Branch Director for the COVID-19 Incident Command for Salt Lake County, where she directed the vaccination strategies for 1.2 million residents of Salt Lake County. She has been a vaccine champion for over 30 years.  Learn more: Download this practical infographic to help you integrate RSV vaccination into your clinical practice. https://bit.ly/43mzacq For more information for nurses, subscribe to the PCE podcast channel on your favorite player! 

Listen in as Evette Whaley and Katie Smiley PA-C talk about innovative strategies for NPs and PAs to improve treatment for pediatric patients with atopic dermatitis. They discuss how to assess the whole patient and their family to better understand the impact of the disease on their quality of life. They also discuss newer treatments and how they can be incorporated into a comprehensive management plan for pediatric patients and their caregivers.  Presenters: Evette Whaley Caregiver Baltimore, Maryland  Katie Smiley PA-C Grants & Clinical Director Program Coordinator, Multidisciplinary Atopic Dermatitis Program Allergy & Asthma Medical Group Rady Children’s Hospital San Diego, California Link to full program: https://bit.ly/43svVyJ

Listen in as rheumatology experts Alexis Ogdie, MD, MSCE, and Julia Swafford, PA-C, DFAAPA, discuss emerging therapies and strategies in managing patients with axial spondyloarthritis or psoriatic arthritis, including: The current treatment landscape (eg, small molecules, biologics) Risk factors to consider when prescribing JAK inhibitors Key considerations regarding comorbidities, especially in addressing depression, anxiety, or social ideation  Nonpharmacologic options to improve treatment outcomes Shared decision-making strategies to enhance patients’ investment in their care Presenter: Alexis Ogdie, MD, MSCE Director, Penn Psoriatic Arthritis and Spondylarthritis Program Director, Penn Center for Clinical Epidemiology and Biostatistics University of Pennsylvania Philadelphia, Pennsylvania Julia Swafford, PA-C, DFAAPA President of SPAR Bronson Battle Creek Rheumatology Specialists Battle Creek, Michigan Link to full program:  bit.ly/4gkTzSv

In this episode, learn how early and sustained HBV care can be enhanced by expanding the role of primary care providers in HBV management. Learn how to: Engage key stakeholders in the provision of HBV care​ Provide HBV management resources to support PCPs who are doing screening​ Consider specialty and primary care collaborations that empower PCPs with clear guidance on how to manage patients living with HBV Presenters: Su Wang, MD, MPH, FACP Medical Director Center for Asian Health and Viral Hepatitis Programs Cooperman Barnabas Medical Center RWJBarnabas-Rutgers Medical Group Associate Member Health Care Policy and Aging Research The Rutgers Institute for Health Senior Advisor Global Health, Hepatitis B Foundation Florham Park, New Jersey Richard R. Andrews, MD, MPH President, Houston Viral Hepatitis Task Force Former Co-Chair, National Task Force on Hepatitis B Board-Certified Family Medicine Addiction Medicine Physician Houston, Texas Ruth Brogden, MPH Patient Advocate Amy S. Tang, MD Former Co-Chair, National Task Force on Hepatitis B Director of Immigrant Health North East Medical Services San Francisco, California Link to full program:  https://bit.ly/3TuqFHI

In this episode, Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, consider barriers and solutions for more expansive HBV treatment in the United States. Topics include: Patient subgroups to consider for treatment outside guideline criteria Adverse event and cost-effectiveness considerations Integration of patient perspectives in wider treatment Presenters: Mark S. Sulkowski, MD, FIDSA, FAASLD Professor of Medicine Director, Division of Infectious Diseases, Johns Hopkins Bayview Medical Center Johns Hopkins University School of Medicine Baltimore, Maryland Tatyana Kushner, MD, MSCE Associate Professor Division of Liver Diseases Icahn School of Medicine at Mount Sinai New York, New York Paul Y. Kwo, MD Professor of Medicine Director of Hepatology Stanford University School of Medicine Palo Alto, California Jacki Chen, PhD Patient Advocate  Link to full program:  https://bit.ly/3TuqFHI Link to the slides: https://bit.ly/4a60GM4 Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.

In this episode, Arun B. Jesudian, MD, and Mazen Noureddin, MD, MHSc, discuss the expert-informed clinical pathway for the multidisciplinary care of patients with MASLD or MASH, current and emerging therapeutics, and management optimization strategies.  Presenters: Arun B. Jesudian, MD Associate Professor of Clinical Medicine Division of Gastroenterology and Hepatology Weill Cornell Medicine New York, New York Mazen Noureddin, MD, MHSc Professor of Medicine Houston Methodist Hospital Director  Houston Research Institute Houston, Texas Content based on an online CME program supported by independent educational grants from Novo Nordisk. To view the full program on “Clinical Pathways: Multidisciplinary Approach to Managing Metabolic Dysfunction‒Associated Steatohepatitis,” including 4 CME/CE-certified text modules with accompanying slidesets, 4 ClincalThought commentaries, and a downloadable infographic resource on the AGA MASLD MASH Clinical Care Pathway, visit clinicaloptions.com or click on the link below. Link to full program: https://bit.ly/3Tyu7At

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include: Updated CDC recommendations for one-time universal screening for HBV Addressing patient-, provider-, and system-level barriers to universal HBV screening Best practices for implementation of HDV screening Presenters: Douglas Dieterich, MD Director, Institute for Liver Medicine Professor of Medicine Division of Liver Diseases Mount Sinai School of Medicine New York, New York Camilla S. Graham, MD, MPH Co-Director, Viral Hepatitis Clinic Division of Infectious Diseases Beth Israel Deaconess Medical Center Harvard Medical School Boston, Massachusetts Robert Wong, MD, MS  Clinical Associate Professor Division of Gastroenterology and Hepatology Stanford University School of Medicine Palo Alto, California Link to full program: https://bit.ly/3TuqFHI Link to the slides:  https://bit.ly/4atS42z

In this episode, Renslow Sherer, MD, and Trinh P. Vu, PharmD, BCIDP, discuss strategies for managing ambulatory patients with acute or previous COVID-19 infection, including: Current COVID-19 landscape Rapid antigen tests and PCR tests Risk stratification of patients who have a positive SARS-CoV-2 test Antiviral treatment (nirmatrelvir + ritonavir, remdesivir, and molnupiravir) Long COVID Presenters: Renslow Sherer, MD Director, International HIV Training Center Professor of Medicine Section of Infectious Diseases and Global Health Department of Medicine University of Chicago Chicago, Illinois Trinh P. Vu, PharmD, BCIDP Clinical Pharmacy Specialist in Infectious Diseases Department of Pharmaceutical Services Emory University Hospital Midtown Atlanta, Georgia To download the slides: bit.ly/3oHKC09 To view the full online program: bit.ly/4201xcO

In this episode, Jona Tanguay, MMSc, PA-C, AAHIVS discusses considerations to review with patients to empower them to make their own informed choices in PrEP selection, including: Leveraging PrEP options with unique dosing schedules and/or routes such as long-acting cabotegravir and on-demand 2-1-1 FTC/TDF Differences in adverse effect profiles between 4 PrEP options Potential for HIV resistance Requirements for compliance and monitoring Evidence in populations with various acquisition behaviors Drug interaction implications   Faculty:  Jona Tanguay, MMSc, PA-C, AAHIVS Health Care Provider and HIV Specialist  Whitman-Walker Health Vice President for Education, GLMA: Health Professionals Advancing LGBTQ Equality Clinical Instructor, Yale University School of Nursing  Washington, DC   Link to full program: https://bit.ly/41WF54o

In this episode, Julie Parsons, MD, discusses the genetic diagnosis of spinal muscular atrophy (SMA), anticipated clinical findings, the importance of newborn screenings, and the next steps to consider after a positive diagnosis is obtained. This high-level overview includes: SMA as an autosomal recessive disease Differences in spinal motor neurons (SMN) 1 and 2 at the time of diagnosis and how these drive severity of disease Important clinical findings in the diagnosis of SMA, as every child may not be identified with newborn screening The importance of newborn screening and critical next steps and logistical considerations when receiving a positive screen in your practice Presenters: Julie Parsons, MD Co-Director, Neuromuscular Clinic Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders Professor of Clinical Pediatrics and Neurology Children’s Hospital Colorado Denver, Colorado Vanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN Senior Director of Nursing, Palliative Care Psychosocial Oncology and Palliative Care Dana-Farber Cancer Institute Boston, Massachusetts  Supported by an educational grant from Biogen Link to full program:  bit.ly/41kw2dK Link to CME: Claim credit -  bit.ly/40eyBwr  

In this episode, Dr. Parsons and Dr. Battista discuss current and emerging medical therapies for the treatment of spinal muscular atrophy (SMA). They review safety, efficacy, and monitoring parameters of current agents, as well as adjuct therapies in the medication pipeline. This high-level overview includes: Review of FDA-approved medical therapies: nusinersen, onasemnogene abeparvovec-xioi, and risdiplam Discussion of the safety, efficacy, and monitoring parameters for FDA approved medications, as well as adjuctive agents for medication therapy complications Review of ongoing clinical trials on anti-myostatin medications and discussion of the role these agents would play if approved by the FDA Presenters: Julie Parsons, MD Co-Director, Neuromuscular Clinic Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders Professor of Clinical Pediatrics and Neurology Children’s Hospital Colorado Denver, Colorado Vanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN Senior Director of Nursing, Palliative Care Psychosocial Oncology and Palliative Care Dana-Farber Cancer Institute Boston, Massachusetts Supported by an educational grant from Biogen Link to full program: bit.ly/41kw2dK Link to CME: Claim credit - bit.ly/40fkDKD  

In this episode, Dr. Battista and Dr. Parsons discuss the importance of care guidelines and the multidisciplinary team in the treatment of spinal muscular atrophy (SMA). This overview will include: The role each member of the interdisciplinary team plays in the care of SMA including physical therapists, occupational therapists, and speech therapists The importance of continued, ongoing therapy in addition to medication therapy to provide the greatest improvement in SMA care How to manage transitions in care, including the transition from pediatrics to adulthood and how to include the necessary support teams The role shared decision-making plays in the treatment of patients with SMA Presenters: Julie Parsons, MD Co-Director, Neuromuscular Clinic Haberfeld Family Endowed Chair in Pediatric Neuromuscular Disorders Professor of Clinical Pediatrics and Neurology Children’s Hospital Colorado Denver, Colorado Vanessa Battista, DNP, MBA, RN, MS, CPNP-PC, CHPPN, FPCN Senior Director of Nursing, Palliative Care Psychosocial Oncology and Palliative Care Dana-Farber Cancer Institute Boston, Massachusetts Supported by an educational grant from Biogen. Link to full program:  https://bit.ly/43Dmo7q Link to CME: Claim credit https://bit.ly/40gulfX  

In this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on: Viral coinfections such as influenza and RSV New data comparing baricitinib and tocilizumab for patients with severe COVID-19 Management of bacterial and fungal coinfection while incorporating antimicrobial stewardship Tips for transitioning patients out of the ICU and to the medical floor or home Presenters: Vikramjit Mukherjee, MD Assistant Professor   Division of Pulmonary, Critical Care, & Sleep Medicine   New York University School of Medicine   Director Medical Intensive Care Unit Bellevue Hospital New York Cameron Smith MPAS, PA-C Lead Advanced Practice Provider Medical Intensive Care Unit Bellevue Hospital New York Health and Hospitals   New York Content based on an online program supported by an independent educational grant from Gilead Sciences, Inc. Link to full program:  bit.ly/3z52c00

In this episode, Vikramjit Mukherjee, MD, and Cameron Smith, MPAS, PA-C, answer audience questions on how best to care for hospitalized patients with COVID-19 from a live, virtual question and answer webinar. This episode includes expert insights on: Supportive care management such as oxygen support, glycemic control, and anticoagulation Escalation of therapy in patients with worsening oxygen requirements Use of remdesivir in patients with renal dysfunction Brief commentary on long COVID Presenters: Vikramjit Mukherjee, MD Assistant Professor   Division of Pulmonary, Critical Care, & Sleep Medicine   New York University School of Medicine   Director Medical Intensive Care Unit Bellevue Hospital New York Cameron Smith MPAS, PA-C Lead Advanced Practice Provider Medical Intensive Care Unit Bellevue Hospital New York Health and Hospitals   New York, New York Content based on an online program supported by an independent educational grant from Gilead Sciences, Inc. bit.ly/3z52c00

In this podcast, Susan LeLacheur, DrPH, PA-C, AAHIVS discusses racial disparities in access to HIV prevention (PrEP) and strategies to close these gaps, including: Incorporating comprehensive sexual history into medical appointments and offering PrEP to all sexually active patients Increase awareness of PrEP access programs in communities of color Diversification of the medical workforce Faculty:  Susan LeLacheur, DrPH, PA-C, AAHIVS Professor Department of Physician Assistant Studies School of Medicine and Health Sciences The George Washington University Washington, DC Link to full program: https://practicingclinicians.com/content/hiv-prevention-resource-center

This podcast episode is part of a multimedia program reviewing the management of nontuberculous mycobacterial lung disease (NTM-LD). Tune in to hear Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC, and Anne O’Donnell, MD, highlight the diagnostic criteria and optimal treatment strategies in patients with NTM-LD. The overview will include:  Recommended assessments and tests to appropriately diagnosis NTM-LD in patients A summary of the current guidelines for the management of NTM-LD, including appropriate monitoring of medications. Guidance on how to individualize treatment plans for patients with NTM-LD based on disease and patient characteristics Presenters:  Jennifer Faber-Gerling, RN, MS, CNS, ANP-BC Nurse Practitioner Division of Mycobacterial and Respiratory Infections National Jewish Health Denver, Colorado Anne O’Donnell, MD Professor of Medicine Division of Pulmonary, Critical Care, and Sleep Medicine Georgetown University Medical Center Washington, DC To view other program offerings, including a CE-certified on-demand webcast, a Q&A text module, and to download slides, visit pce.is/NTM.

In this episode, Tracy Zivin-Tutela, MD, answers audience questions on how best to care for patients at high risk of complications due to influenza from a live virtual meeting series. This episode includes expert insights on: Emerging resistance patterns of currently used antivirals Getting the flu vaccine after treatment with antivirals Use of antivirals in patients who test positive for flu and COVID-19 Techniques and over-the-counter therapies other than yearly vaccination to avoid severe complications due to the flu  Avoiding dairy after receiving baloxavir Insurance coverage for antivirals Considering bacterial and viral coinfection in patients with lung disease Retreating high-risk patients with antivirals after another flu exposure Calculating flu rates Presenter: Tracy Zivin-Tutela, MD Attending Physician Division of Infectious Diseases Department of Medicine Los Alamitos Medical Center, Fountain Valley Regional Hospital New Brunswick, California Daniel Zalinov, PA-C Atrium Health Charlotte, North Carolina Link to full program: https://bit.ly/3GMokRC

In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss the expanding treatment armamentarium for MS, the complexities involved in making treatment selection, patient factors to consider when individualizing treatment, and how best to talk with patients about their options within the context of shared decision-making. Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics; researcher: Biogen, Bristol-Myers Squibb, Novartis, Sanofi. Allison L. Boyd, MPAS, PA-C, MSCS: consultant/advisor/speaker: EMD Serono.

In this episode, Stephen Krieger, MD, and Allison Boyd, MPAS, PA-C, MSCSdiscuss timely recognition of MS, including insights into why early recognition can lead to early treatment, which can decrease the risk of disability progression and produces better outcomes. Challenges discussed include the variable clinical presentation of MS and the lack of specific tests. The experts also discuss how to avoid missed diagnosis and misdiagnosis.    Stephen Krieger, MD: consultant/advisor/speaker: Biogen, EMD Serono, Genentech, Genzyme/Sanofi, Novartis, Octave, TG Therapeutics; researcher: Biogen, Bristol-Myers Squibb, Novartis, Sanofi. Allison L. Boyd, MPAS, PA-C, MSCS: consultant/advisor/speaker: EMD Serono.